Hiring in life sciences? Share your open positions with our professional community. Read more Close

Advertisement

Ligand-Dependent Affinity but State-Dominated Efficacy in Structure-Based GPCR Pharmacology Prediction.

Created on 12 Nov 2026

Authors

Jianxiang Huang, Xin Qiao, Chunhao Zhu, Xiaobing Lan, Shaoyong Lu

Published in

Journal of medicinal chemistry. Volume 69. Issue 21. Pages 26595-26611. Nov 12, 2026.

Abstract

High accuracy in structure-based prediction of G protein-coupled receptor (GPCR) efficacy may reflect the receptor state rather than ligand-specific information. We addressed these information sources using state rules, ligand-blind baselines, matched receptor-state contrasts, ligand permutation, and out-of-distribution (OOD) evaluation, with affinity prediction as a positive control. State rules and ligand-blind geometry achieved binary-efficacy-balanced accuracies of 0.844-0.910 and 0.777-0.870, respectively. Of 75 ligand-aware evaluations, 72 failed at least one prespecified ligand-sensitivity condition, and three lacked required evidence; none met all required criteria. Affinity pretraining gave no detectable efficacy benefit over matched random initialization. In contrast, ligand chemistry supported affinity prediction across 14,740 measured pairs, and all 12 primary affinity permutation comparisons deteriorated, although this advantage did not persist under scaffold, family, or combined OOD splits. Accuracy on endpoint structures therefore cannot alone establish ligand-specific efficacy learning; the findings do not set a general limit on such learning.

PMID:
43018561
Bibliographic data and abstract were imported from PubMed on 12 Nov 2026.

Read full publication at:
Please sign in to see all details.

Advertisement

Stats

  • Community rating n/a 0 votes
  • Reviewers' rating n/a 0 votes
  • Your rating

1-terrible, 9-excellent. How would you rate this publication? Sign in in to submit your rating.

  • Recommendations n/a n/a positive of 0 vote(s)
  • Views 3
  • Comments 0

Recommended by

  • No recommendations yet.

Post a comment

You need to be signed in to post comments. You can sign in here.

Comments

There are no comments yet.

Advertisement